Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?

Eliza Hawkes, David Cunningham

Research output: Contribution to journal › Letter › Other › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1020-1021
Number of pages	2
Journal	The Lancet Oncology
Volume	11
Issue number	11
DOIs	https://doi.org/10.1016/S1470-2045(10)70211-4
Publication status	Published - Nov 2010
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(10)70211-4

Other files and links

Link to publication in Scopus

Cite this

@article{e8f5ca1e9bac4a3e9914ff17ebab7515,

title = "Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?",

author = "Eliza Hawkes and David Cunningham",

year = "2010",

month = nov,

doi = "10.1016/S1470-2045(10)70211-4",

language = "English",

volume = "11",

pages = "1020--1021",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier",

number = "11",

}

TY - JOUR

T1 - Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?

AU - Hawkes, Eliza

AU - Cunningham, David

PY - 2010/11

Y1 - 2010/11

UR - http://www.scopus.com/inward/record.url?scp=78049524827&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(10)70211-4

DO - 10.1016/S1470-2045(10)70211-4

M3 - Letter

C2 - 21051017

AN - SCOPUS:78049524827

SN - 1470-2045

VL - 11

SP - 1020

EP - 1021

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 11

ER -